References
- Rosenblatt J E, Kind A C, Brodie J L, Kirby W MM. Mechanisms responsible for the blood level differences of isoxazolyl penicillins. Arch Intern Med 1968; 121: 345–348
- Gravenkemper C F, Bennet J V, Brodie J L, Kirby W MM. Dicloxacillin. In vitro and pharmacologic comparisons with oxacillin and cloxacillin. Arch Intern Med 1965; 116: 340–345
- Stewart G T. Clinical and laboratory results with BRL 1621. A report from six hospitals. Lancet 1962; 2: 634–639
- Sutherland R, Croydon E AP, Rolinson G N. Flucloxacillin, a new isoxazolyl penicillin, compared with oxacillin, cloxacillin, and dicloxacillin. Br Med J 1970; 4: 455–460
- Siersbaeck-Nielsen K, Mölholm-Hansen J, Kampmann J, Kristensen M. Rapid evaluation of creatinine clearance. Lancet 1971; 1: 1133–1134
- Leikola E, Vartia K O. On penicillin levels in young and geriatric subjects. J Gerontol 1957; 12: 48–52
- Rouan M C, Binswanger U, Bammatter F, Theobald W, Schoeller P, Guiberts J P. Pharmacokinetics and dosage adjustment of cefotiam in renal impaired patients. J Antimicrob Chemother 1984; 13: 611–618
- Nauta E H, Mattie H. Dicloxacillin and cloxacillin: Pharmacokinetics in healthy and hemodialysed subjects. Clin Pharmacol Ther 1976; 20: 98–108
- Cole L, Kenig M D, Hewitt V A. Metabolism of penicillins to penicilloic acids and 6-aminopenicillinaic acid in man and its significance in assessing penicillin absorption. Antimicrob Agents Chemother 1973; 3: 463–469
- Norrby S R, Rogers J D, Ferber F, Jones K H, Zacchei A G. Weidner LL, Demitriades JL, Gravallese DA, Hsieh JYK. Disposition in man of imipenem and cilastatin: Studies with radiolabeled imipenem and cilastatin. Antimicrob Agents Chemother 1984; 27: 707–714
- Swabb E A, Singhri S M, Keitz M A, Fantz M, Sugerman A A. Metabolism and pharmacokinetics of aztreonam in healthy subjects. Antimicrob Agents Chemother 1983; 24: 394–400
- Isacsson J, Collert S. Renal impairment after high doses of dicloxacillin-prophylaxis in joint replacement surgery. Acta Orthop Scand 1984; 55: 407–410